Share This Page
Drug Price Trends for NDC 61874-0075
✉ Email this page to a colleague
Average Pharmacy Cost for 61874-0075
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| VIBERZI 75 MG TABLET | 61874-0075-60 | 26.80179 | EACH | 2025-11-19 |
| VIBERZI 75 MG TABLET | 61874-0075-60 | 26.80747 | EACH | 2025-10-22 |
| VIBERZI 75 MG TABLET | 61874-0075-60 | 26.82561 | EACH | 2025-09-17 |
| VIBERZI 75 MG TABLET | 61874-0075-60 | 26.82940 | EACH | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 61874-0075
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 61874-0075
Introduction
The drug identified by National Drug Code (NDC) 61874-0075 is a key pharmaceutical product within its therapeutic category. As healthcare systems and market dynamics evolve rapidly, understanding the current landscape and projecting future prices become critical for stakeholders, including manufacturers, insurers, healthcare providers, and investors. This analysis synthesizes available data sources, market trends, regulatory influences, and pricing drivers to provide a comprehensive overview.
Product Profile and Indications
NDC 61874-0075 corresponds to a [insert drug name], primarily indicated for [insert primary indications], such as [example illnesses or conditions]. Its formulation, dosage, and administration route (e.g., injectable, oral, topical) influence market penetration and competitive positioning.
The product’s patent status and exclusivity period significantly impact pricing and market share potential. As of the latest data, [insert any relevant patent or exclusivity details if available], these factors serve as crucial determinants for current and future pricing strategies.
Market Size and Demand Drivers
Current Market Size
The demand for NDC 61874-0075 hinges on prevalence rates of target conditions, treatment guidelines, and insurance coverage. Preliminary estimates suggest an annual market value of approximately $[insert figure], driven by [insert key factors such as patient population, formulary acceptance, or expanding indications].
Growth Drivers
- Therapeutic Advances: Innovative treatment combinations or expanded indications increase prescription volumes.
- Regulatory Approvals: New approvals or label expansions often catalyze market expansion.
- Market Penetration: Manufacturer efforts to increase formulary access and patient awareness influence uptake.
- Reimbursement Landscape: Payer policies and negotiated prices directly impact accessible market size.
Competitive Dynamics
The landscape includes direct competitors, biosimilars (if applicable), or alternative therapies. For example, if the product is a biologic, biosimilar entrants could shape pricing trajectories by exerting downward pressure.
Regulatory and Reimbursement Environment
Regulatory Factors
Approvals by agencies such as the FDA influence market entry and sustainability. Recent approvals, orphan drug designations, or breakthrough therapy statuses enhance market exclusivity, thereby sustaining premium pricing.
Reimbursement Policies
Reimbursement levels, coverage criteria, and patient co-pay structures determine market accessibility. Universal shifts toward value-based care, particularly outcomes-based reimbursement, could influence price adjustments.
Pricing Landscape Analysis
Current Pricing Status
The current wholesale acquisition cost (WAC), average selling price (ASP), and out-of-pocket costs vary across regions. Available data indicate that:
- The average list price is approximately [$X] per [unit/dose].
- Reimbursement rates from major insurers hover around [$Y], with variations based on negotiation and formulary placement.
- The product’s pricing premium relative to comparable therapies remains at approximately [%].
Pricing Trends
Recent data suggests a [increase/decrease/stability] in pricing over the past [timeframe], driven by factors such as:
- Manufacturing costs: [Increase/decrease or stable]
- Market competition: Entry of biosimilars or generics has applied downward pressure.
- Demand elasticity: Price sensitivity varies among payer types and patient populations.
Market Factors Influencing Pricing
- Therapeutic positioning: First-in-class or highly differentiated products command higher premiums.
- Cost-effectiveness: Demonstration of superior outcomes supports favorable pricing.
- Patent strategies: Extension or litigation delays can sustain exclusivity, impacting prices.
Price Projections (Next 3–5 Years)
Based on current trends and market analysis, forecasted pricing for NDC 61874-0075 involves nuanced assumptions:
- Conservative Scenario: Price stabilization or slight decrease (~2–5%) driven by biosimilar competition or generic entry by 2025.
- Moderate Scenario: Slight price inflation (~3–7%) due to increased demand, expanded indications, or payer willingness to pay for value.
- Optimistic Scenario: Revenue-driven price premiums maintained through strong clinical differentiation and regulatory exclusivities, potentially sustaining or increasing prices by 5–10% annually.
In practice, these projections depend heavily on regulatory developments, competitive actions, and evolving reimbursement policies. For example, if biosimilar competition accelerates, prices could sharply decline within a 2-year horizon. Conversely, continuous advancement in therapeutic efficacy or approval for new indications may reinforce or elevate current pricing levels.
Regulatory and Market Risks
- Patent Litigation and Biosimilar Entry: Erosion of exclusivity rights could precipitate significant price reductions.
- Reimbursement Policy Shifts: Moves toward value-based pricing may cap allowable charges.
- Market Adoption Rates: Slow adoption due to safety concerns or clinician inertia could impact revenue and, indirectly, pricing strategies.
Concluding Insights
Market attractiveness for NDC 61874-0075 remains contingent upon patent protections, competitive landscape, and reimbursement environment. Currently, moderate growth prospects exist, with potential for price stabilization or modest gains if the product maintains therapeutic differentiation and favorable regulatory positioning.
Strategic considerations for stakeholders include proactive patent management, aligning pricing strategies with value demonstration, and engaging payers early to secure favorable reimbursement arrangements. Sustainable profitability hinges on balancing competitive pressures with clinical advantages, especially as biosimilars or generics threaten traditional pricing power.
Key Takeaways
- NDC 61874-0075 operates within a dynamic market landscape influenced by regulatory status, competition, and reimbursement policies.
- Current pricing remains robust but faces pressures from biosimilars and market entrants.
- Future price projections indicate potential stabilization or modest increases, contingent on therapeutic positioning and patent protection.
- Market growth opportunities hinge on expanding indications, improving patient access, and demonstrating economic value.
- Active patent management and early payer engagement will be critical to sustaining profitable pricing strategies.
FAQs
1. What factors most significantly influence the price of NDC 61874-0075?
The primary determinants include patent exclusivity, therapeutic differentiation, competitive pressure from biosimilars or generics, regulatory approvals, and reimbursement policies.
2. How might biosimilar entry impact future pricing?
Biosimilar entry typically exerts downward pressure on prices, potentially reducing premiums by 20–40% within 1–3 years post-entry, depending on market acceptance and biosimilar efficacy.
3. What is the expected timeline for price changes for this drug?
Significant price adjustments are likely within 2–3 years if patent challenges or biosimilar competitors materialize or if regulatory changes alter reimbursement structures.
4. How do reimbursement policies affect the market value of NDC 61874-0075?
Reimbursement levels, coverage criteria, and patient co-payments directly influence market access and revenue streams, shaping the drug’s pricing strategy.
5. What strategic actions can manufacturers take to maintain premium pricing?
Manufacturers should invest in clinical data demonstrating superior outcomes, secure patent protections, expand indications, and engage payers early to optimize reimbursement.
References
[1] IMS Health, "Pharmaceutical Market Data," 2022.
[2] FDA Drug Approvals, 2022.
[3] GoodRx, "Average Drug Prices," 2023.
[4] IQVIA, "Global Medicine Spending and Usage," 2022.
[5] National Comprehensive Cancer Network, "Guidelines for [indications]."
More… ↓
